HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $55 | -29.5% | 36,624 | +17.3% | 0.00% | -100.0% |
| Q4 2022 | $78 | -100.0% | 31,224 | -19.4% | 0.00% | 0.0% |
| Q3 2022 | $163,000 | +270.5% | 38,719 | +148.3% | 0.00% | – |
| Q2 2022 | $44,000 | -61.4% | 15,596 | -22.1% | 0.00% | -100.0% |
| Q1 2022 | $114,000 | -32.1% | 20,017 | +8.5% | 0.00% | 0.0% |
| Q4 2021 | $168,000 | +12.8% | 18,443 | +31.9% | 0.00% | 0.0% |
| Q3 2021 | $149,000 | -15.3% | 13,983 | +23.0% | 0.00% | 0.0% |
| Q2 2021 | $176,000 | -27.0% | 11,366 | +49.2% | 0.00% | -50.0% |
| Q3 2018 | $241,000 | -47.5% | 7,616 | -35.5% | 0.00% | -33.3% |
| Q2 2018 | $459,000 | +30.0% | 11,813 | -7.7% | 0.00% | +50.0% |
| Q1 2018 | $353,000 | +29.8% | 12,798 | -15.0% | 0.00% | 0.0% |
| Q4 2017 | $272,000 | +262.7% | 15,053 | +263.8% | 0.00% | +100.0% |
| Q2 2016 | $75,000 | +2.7% | 4,138 | +8.1% | 0.00% | – |
| Q1 2016 | $73,000 | +1.4% | 3,827 | +41.1% | 0.00% | -100.0% |
| Q4 2015 | $72,000 | – | 2,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |